Advanced search
Companies (980)
Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net ...
Capitalization | 143 B USD |
---|---|
Change | +1.71% |
1-year price change | -12.45% |
Asahi Group Holdings, Ltd. specializes in the production and marketing of beer and non alcoholic beverages. Net sales break down by family of products as follows: - alcoholic beverages (31%): beer, liqueurs, wine and whisky (brands Asahi Super Dry, Asahi ...
Capitalization | 18 502 M USD |
---|---|
Change | +0.31% |
1-year price change | +9.19% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Capitalization | 12 207 M USD |
---|---|
Change | +1.73% |
1-year price change | +25.12% |
Ares Capital Corporation is a specialty finance company focused on providing direct loans and other investments in private middle market companies in the United States. The Company invests primarily in first lien senior secured loans (including unitranche ...
Capitalization | 13 255 M USD |
---|---|
Change | +0.70% |
1-year price change | +7.69% |
Airports of Thailand Public Company Limited is a Thailand-based company that is engaged in airport operations and other business related to or affiliated with the airport business. The Company is engaged in airport management business, hotel business, gro ...
Capitalization | 25 216 M USD |
---|---|
Change | +1.56% |
1-year price change | +8.79% |
Dubai Electricity and Water Authority PJSC is a United Arab Emirates-based utility services provider. The Company distributes electricity and water and serves residential and commercial customers in the United Arab Emirates. The principal activities of th ...
Capitalization | 31 170 M USD |
---|---|
Change | +1.33% |
1-year price change | -6.91% |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination ant ...
Capitalization | 8 873 M USD |
---|---|
Change | -3.39% |
1-year price change | +77.64% |
PT Champ Resto Indonesia, Tbk is an Indonesia-based company that operates restaurants. It owns brands, such as Raa Cha, Gokana, BMK, Platinum, Chopstix and Monsieur Spoon. Raa Cha presents a way of dining, equipped with personal and cooking utensils. Goka ...
Capitalization | 139 M USD |
---|---|
Change | +0.48% |
1-year price change | -19.31% |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 7 293 M USD |
---|---|
Change | -7.66% |
1-year price change | -33.51% |
Puer Lancang Ancient Tea Co Ltd is a China-based company principally engaged in the manufacture of tea products. The Company is a primarily engaged in the production of tea products, food production and sales. The Company's main brand is Lancang Ancient T ...
Capitalization | 136 M USD |
---|---|
Change | +0.79% |
1-year price change | +23.30% |
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Companyâs technologies are designed to administer disease-fighting genes to provide new therapies for large patient populat ...
Capitalization | 7 M USD |
---|---|
Change | +28.51% |
1-year price change | -66.20% |
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of ...
Capitalization | 28 M USD |
---|---|
Change | -0.83% |
1-year price change | +63.21% |
CHA Vaccine Research Institute Co Ltd is a Korea-based company principally engaged in the vaccines and immunotherapy research business based on based on adjuvant platform technology. The Company is engaged in the research and development (R&D) of premium ...
Capitalization | 90 M USD |
---|---|
Change | -0.75% |
1-year price change | -17.79% |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bi ...
Capitalization | 6 097 M USD |
---|---|
Change | -20.47% |
1-year price change | +232.76% |
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical ...
Capitalization | 7 324 M USD |
---|---|
Change | -0.14% |
1-year price change | -17.66% |
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Capitalization | 13 M USD |
---|---|
Change | +2.58% |
1-year price change | +2.05% |
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
Capitalization | 40 M USD |
---|---|
Change | +3.45% |
1-year price change | -24.05% |
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered ...
Capitalization | 208 M USD |
---|---|
Change | +5.93% |
1-year price change | -22.28% |
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Capitalization | 8 359 M USD |
---|---|
Change | -.--% |
1-year price change | +5.33% |
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for t ...
Capitalization | 18 M USD |
---|---|
Change | -0.58% |
1-year price change | +15.65% |
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | -100.00% |
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
Capitalization | 6 610 M USD |
---|---|
Change | -0.75% |
1-year price change | +14.44% |
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations ...
Capitalization | 1 272 M USD |
---|---|
Change | +3.89% |
1-year price change | +28.43% |
ROUND ONE Corporation is a Japan-based company principally mainly engaged in the comprehensive amusement business. The Company operates in two geographic segments: Japan and the United States. The Company is engaged in the operation of indoor leisure comp ...
Capitalization | 1 196 M USD |
---|---|
Change | +4.81% |
1-year price change | +24.91% |
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resista ...
Capitalization | 5 M USD |
---|---|
Change | -2.17% |
1-year price change | -87.20% |
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated c ...
Capitalization | 167 M USD |
---|---|
Change | -3.79% |
1-year price change | -25.73% |
Peak Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on commercializing therapeutics that aim to improve and address unmet medical needs for patients with inflammatory, rare and specialty diseases and cancer. The Companyâ ...
Capitalization | 198 874 USD |
---|---|
Change | -.--% |
1-year price change | -95.41% |
4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sens ...
Capitalization | 153 M USD |
---|---|
Change | +0.85% |
1-year price change | -17.48% |
SAN FU CHEMICAL Co., Ltd. is a Taiwan-based company primarily engaged in the production and sales of fine chemicals and basic chemicals. Its fine chemicals include developers, etchants, stripping liquid, dilution and washing liquid products. Its basic che ...
Capitalization | 438 M USD |
---|---|
Change | +0.35% |
1-year price change | +12.75% |
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | +43.75% |
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Capitalization | 8 M USD |
---|---|
Change | -.--% |
1-year price change | -14.10% |
LungLife AI, Inc. is a developer of clinical diagnostic solutions for lung cancer. The Company is engaged in the development and commercialization of its lung cancer early detection test. Using a minimally invasive blood draw, its LungLB test is designed ...
Capitalization | 7 M USD |
---|---|
Change | -.--% |
1-year price change | -58.70% |
Kyoto Financial Group Inc is a Japan-based company mainly engage in the management and administration of banks and other companies that may be made subsidiaries under the Banking Law, as well as other businesses incidental and related thereto. The Kyoto B ...
Capitalization | 5 236 M USD |
---|---|
Change | +3.39% |
1-year price change | +28.27% |
Lyft, Inc. is a multimodal transportation network in the United States and Canada that offer access to a variety of transportation options through its platform and mobile-based applications. The Lyft Platform provides a marketplace where drivers can be ma ...
Capitalization | 6 298 M USD |
---|---|
Change | -0.95% |
1-year price change | +4.14% |
Australian Foundation Investment Company Limited is an investment company, which is focused on investing in Australian and New Zealand equities. Its investment objective is to provide shareholders with investment returns through access to a stream of fran ...
Capitalization | 5 950 M USD |
---|---|
Change | -.--% |
1-year price change | -3.89% |
AGNC Investment Corp. is an internally managed real estate investment trust (REIT). The Company provides private capital to the United States housing market, enhancing liquidity in the residential real estate mortgage markets and, in turn, facilitating ho ...
Capitalization | 7 058 M USD |
---|---|
Change | +1.27% |
1-year price change | -2.24% |
Restoque Comercio e Confeccoes de Roupas SA, formerly Le Lis Blanc Deux Comercio e Confeccoes de Roupas SA, is a Brazil-based company primarily engaged in the fashion industry. The Company focuses on the design, development, manufacture and trade of appar ...
Capitalization | 348 M USD |
---|---|
Change | +9.93% |
1-year price change | -24.02% |
Kuber Resources Corp is engaged in trading, distribution, and consultancy company. The Company focuses on tea planting and sales, research, and development. The Companyâs business scope includes partnering with tea plantations for tea production, such a ...
Capitalization | 637 M USD |
---|---|
Change | -11.93% |
1-year price change | -12.73% |
PIMCO Dynamic Income Fund (the Fund) is a diversified closed-end management investment company. The Funds primary investment objective is to seek current income and secondary objective is capital appreciation. The Fund normally invests worldwide in a port ...
Capitalization | 5 271 M USD |
---|---|
Change | +0.36% |
1-year price change | +7.30% |
La Française des Jeux (FDJ) is the leading gambling operator in France. The activity is organized around 2 categories of games: - lottery games: draw games (Lotto®, Euromillions, Bingo Live, KENO Gagnant à Vie, etc.) and instant games (Millionaire, Cash, ...
Capitalization | 6 609 M USD |
---|---|
Change | -1.14% |
1-year price change | +0.37% |
FS KKR Capital Corp. is an externally managed, non-diversified, closed-end management investment company, which regulates as a business development company (BDC). It is focused on providing customized credit solutions to private middle market United State ...
Capitalization | 5 741 M USD |
---|---|
Change | +1.23% |
1-year price change | +2.65% |
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Companyâs LungFit platfo ...
Capitalization | 59 M USD |
---|---|
Change | +4.07% |
1-year price change | -34.69% |
Terreno Realty Corporation acquires, owns, and operates industrial real estate in six coastal markets in the United States, such as Los Angeles; Northern New Jersey/New York City; San Francisco Bay Area; Seattle; Miami, and Washington, District of Columbi ...
Capitalization | 5 472 M USD |
---|---|
Change | +0.84% |
1-year price change | -9.72% |
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. T ...
Capitalization | 84 M USD |
---|---|
Change | -.--% |
1-year price change | -51.50% |
Gunsynd plc is a United Kingdom-based investing company. The Company's investing policy is to invest in and/or acquire companies and/or projects within the natural resources sector, life sciences sector (concentrating on but not being limited to, plant-ba ...
Capitalization | 965 118 USD |
---|---|
Change | -.--% |
1-year price change | -22.22% |
Nuveen Multi-Asset Income Fund (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to provide a total return through high current income and capital appreciation. Under normal circumstances, the Fund ...
Capitalization | 407 M USD |
---|---|
Change | +1.33% |
1-year price change | -0.89% |
JLogo Holdings Limited is a Singapore-based investment holding company, which owns and operates restaurants in Singapore under different brands and owns artisanal bakery chains in Malaysia. Its segments are dining operations and artisanal bakery. The dini ...
Capitalization | 14 M USD |
---|---|
Change | -.--% |
1-year price change | -40.83% |
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio ...
Capitalization | 15 M USD |
---|---|
Change | +2.11% |
1-year price change | +83.54% |
Grande Asset Hotels and Property Public Company Limited is a Thailand-based company. The Company is engaged in hotel, property development and rental businesses. The Company is focused on the investment in internationally and globally managed brand of fou ...
Capitalization | 36 M USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. The Companyâs lead product candidate, avasopasem manganese (avasopase ...
Capitalization | 12 M USD |
---|---|
Change | -6.48% |
1-year price change | +47.94% |
Gyre Therapeutics, Inc. is a biotechnology company. The Company is engaged in the research, development, manufacturing and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of Hydronidone (F351 ...
Capitalization | 971 M USD |
---|---|
Change | +9.13% |
1-year price change | -55.78% |
John Hancock Investors Trust (the Fund) is a closed-end management investment company. The Fund's primary investment objective is to generate income for distribution to its shareholders, with capital appreciation as a secondary objective. The Fund also ma ...
Capitalization | 117 M USD |
---|---|
Change | +0.32% |
1-year price change | +3.86% |
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent pr ...
Capitalization | 1 003 M USD |
---|---|
Change | +0.60% |
1-year price change | -16.29% |
Y Biologics Inc is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as we ...
Capitalization | 94 M USD |
---|---|
Change | +0.69% |
1-year price change | -43.59% |
ST Group Food Industries Holdings Limited is an Australia-based investment holding company. The Companyâs food and beverage retails segment includes operations with respect to all franchise and its owned restaurants and stores. The supply chain segment ...
Capitalization | 30 M USD |
---|---|
Change | -3.59% |
1-year price change | -4.17% |
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delive ...
Capitalization | 15 M USD |
---|---|
Change | -1.24% |
1-year price change | -4.78% |
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powde ...
Capitalization | 503 M USD |
---|---|
Change | -1.19% |
1-year price change | -22.89% |
EV Minerals Corporation is a Canadian exploration company focused on mineral exploration and development. The Company focuses on the EV Nickel Project, the host of the nickel-copper-cobalt deposit. The Project comprises approximately 32 mineral claims cov ...
Capitalization | 2 M USD |
---|---|
Change | +25.00% |
1-year price change | -70.59% |
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with important unmet medical needs using its patent ...
Capitalization | 7 M USD |
---|---|
Change | +1.63% |
1-year price change | +0.54% |
Qiansui International Group Co Ltd, formerly Ariel Clean Energy Inc, is a shell company. The Company is engaged in seeking new business opportunities with business entities for merger with or acquisition of a target business. The Company may seek a busine ...
Capitalization | 7 USD |
---|---|
Change | -99.67% |
1-year price change | -.--% |
abrdn Global Premier Properties Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to seek high current income and capital appreciation. The Fund may invest up to 35% of its managed assets in sec ...
Capitalization | 320 M USD |
---|---|
Change | +3.31% |
1-year price change | -3.35% |
Cadence Opportunities Fund Limited is an Australia-based company, which is engaged in investing primarily in securities listed both in Australia and internationally. The Company may take short positions and may also deal in derivatives for hedging purpose ...
Capitalization | 18 M USD |
---|---|
Change | +0.29% |
1-year price change | +12.91% |
Asia Hotel Public Company Limited is a Thailand-based company. The Companyâs segments include room service, food and beverage and rental of shopping complex, and real estate. The Company and its subsidiaries, Asia Pattaya Hotel Co., Ltd. and Asia Airpor ...
Capitalization | 57 M USD |
---|---|
Change | +0.77% |
1-year price change | +3.97% |
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonarya ...
Capitalization | 983 M USD |
---|---|
Change | +0.08% |
1-year price change | +6.98% |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development ...
Capitalization | 1 371 M USD |
---|---|
Change | +0.94% |
1-year price change | -21.10% |
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapi ...
Capitalization | 749 M USD |
---|---|
Change | -0.31% |
1-year price change | -26.86% |
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidat ...
Capitalization | 1 239 M USD |
---|---|
Change | -2.60% |
1-year price change | +18.46% |
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential onc ...
Capitalization | 59 M USD |
---|---|
Change | -1.23% |
1-year price change | -90.17% |
Savara Inc. is a clinical-stage biopharmaceutical company, which is focused on rare respiratory diseases. The Companyâs lead program, molgramostim nebulizer solution (molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage ...
Capitalization | 565 M USD |
---|---|
Change | -0.49% |
1-year price change | -12.98% |
Aceragen Inc is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious un ...
Capitalization | 3 M USD |
---|---|
Change | +0.58% |
1-year price change | -.--% |
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic ...
Capitalization | 419 M USD |
---|---|
Change | +1.53% |
1-year price change | -23.31% |
Lung Kee Bermuda Holdings Ltd is an investment holding company principally engaged in the mould base business. The Company is engaged in the manufacture and sale of mould bases and related products. The Company sells its products in China, America, Europe ...
Capitalization | 108 M USD |
---|---|
Change | -0.00% |
1-year price change | -7.59% |
Jumbo Group Limited is a Singapore-based investment holding company. It is a multi-dining concept food and beverages (F&B) company. It is engaged in the operation and management of restaurants and manufacturers of food stuff. The Company operates in Singa ...
Capitalization | 112 M USD |
---|---|
Change | -1.96% |
1-year price change | -10.71% |
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commerci ...
Capitalization | 2 369 M USD |
---|---|
Change | -1.17% |
1-year price change | +47.42% |
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is l ...
Capitalization | 28 M USD |
---|---|
Change | -.--% |
1-year price change | -42.39% |
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and m ...
Capitalization | 252 M USD |
---|---|
Change | -.--% |
1-year price change | -27.08% |
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...
Capitalization | 45 M USD |
---|---|
Change | -5.35% |
1-year price change | -39.01% |
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress ...
Capitalization | 739 031 USD |
---|---|
Change | -.--% |
1-year price change | +20.00% |
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodu ...
Capitalization | 119 M USD |
---|---|
Change | -1.70% |
1-year price change | +22.70% |
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing servi ...
Capitalization | 678 M USD |
---|---|
Change | -3.77% |
1-year price change | +8.42% |
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...
Capitalization | 79 M USD |
---|---|
Change | -1.60% |
1-year price change | +10.17% |
Eaton Vance Municipal Bond Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income tax. The Fund invests primarily in debt securities issued by municipali ...
Capitalization | 741 M USD |
---|---|
Change | +0.49% |
1-year price change | +1.68% |
DoubleLine Income Solutions Fund (the Fund) is a diversified, closed-end management investment company. The Fundâs primary investment objective is to seek high current income and its secondary objective is to seek capital appreciation. The Fund seeks to ...
Capitalization | 1 294 M USD |
---|---|
Change | +0.48% |
1-year price change | +2.12% |
TransJamaican Highway Limited is a Jamaica-based company. The Company's core business activity is the development, operation and maintenance of a tolled road network known as the TransJam Highways, which is a 49.9 kilometer (km) tolled motorway with two d ...
Capitalization | 258 M USD |
---|---|
Change | -.--% |
1-year price change | +18.52% |
Charn Issara Development Public Company Limited is a Thailand-based company engaged in the sales or lease of office condominiums and real estate development. The Company operates through four segments: real estate development, lease of office condominiums ...
Capitalization | 17 M USD |
---|---|
Change | -.--% |
1-year price change | +9.62% |
Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer m ...
Capitalization | 41 M USD |
---|---|
Change | +10.24% |
1-year price change | -29.53% |
Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as ...
Capitalization | 34 M USD |
---|---|
Change | -1.61% |
1-year price change | -23.58% |
Qian Yuan Baixing, Inc., through Panjin Chunqiu Century Industrial Co., Ltd. (Chunqiu), is focused on selling goods and services on the Internet. The Company also, through Hangzhou Mai Jin Li Biotechnology Co., Ltd (Mai Jin Li), is an enterprise specializ ...
Capitalization | 664 402 USD |
---|---|
Change | -3.33% |
1-year price change | +386.67% |
Nuveen Select Tax-Free Income Portfolio (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. T ...
Capitalization | 662 M USD |
---|---|
Change | +1.00% |
1-year price change | -4.33% |
Australasian Metals Limited is an Australia-based exploration company. The Company is focused on lithium, gold and bauxite/titanium projects in the Northern Territory and Queensland. The Company's projects include May Queen Gold Project, May Queen South B ...
Capitalization | 3 M USD |
---|---|
Change | -8.00% |
1-year price change | -45.88% |
Invesco Bond Fund (the Fund) is a diversified, closed-end management investment company. The investment objective of the Fund is to seek interest income while conserving capital. The Fund invests primarily in fixed-rate United States investment grade corp ...
Capitalization | 180 M USD |
---|---|
Change | +0.58% |
1-year price change | +3.42% |
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse even ...
Capitalization | 4 236 M USD |
---|---|
Change | -1.29% |
1-year price change | -10.83% |
AdAlta Limited is an Australia-based clinical-stage drug discovery company. The Company is engaged in the development of therapeutic products from its i-body platform. The Company has five active development programs ranging from discovery to Phase II cli ...
Capitalization | 9 M USD |
---|---|
Change | -.--% |
1-year price change | +4.17% |
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | -71.18% |
Great Tang Bid Technology, Inc., formerly ESP Resources, Inc., is a shell company and has no operations. The Company intends to merge or acquire an operating business to commence operations and generate revenue. The Company businesses may include developm ...
Capitalization | - USD |
---|---|
Change | -.--% |
1-year price change | -.--% |
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as t ...
Capitalization | 209 M USD |
---|---|
Change | -2.16% |
1-year price change | +18.78% |
Eaton Vance New York Municipal Bond Fund is a non-diversified, closed-end management investment company. The Fundâs investment objective is to provide current income exempt from federal income tax. During normal market conditions, at least 80% of the Fu ...
Capitalization | 172 M USD |
---|---|
Change | +0.53% |
1-year price change | -0.93% |
MFS Intermediate Income Trust (the Fund) is a diversified closed-end management investment company. The Fundâs investment objective is to seek high current income but may also consider capital appreciation. The Fundâs investment adviser, Massachusetts ...
Capitalization | 299 M USD |
---|---|
Change | +1.16% |
1-year price change | -2.24% |
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colo ...
Capitalization | 32 M USD |
---|---|
Change | +2.33% |
1-year price change | -50.48% |
Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company's primary product is its self-developed icotinib hydrochloride (Conmana), a smal ...
Capitalization | 2 185 M USD |
---|---|
Change | -0.60% |
1-year price change | -26.63% |
- Stock Market
- Advanced search
- May Lung Cha
- Company Profiles